JUNO
Juno Therapeutics, Inc.
JUNO
JUNO
Delisted
JUNO was delisted on the 5th of March, 2018.
237 hedge funds and large institutions have $3.7B invested in Juno Therapeutics, Inc. in 2017 Q4 according to their latest regulatory filings, with 55 funds opening new positions, 92 increasing their positions, 63 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
13% more funds holding
Funds holding: 210 → 237 (+27)
2% more capital invested
Capital invested by funds: $3.62B → $3.7B (+$89.6M)
Holders
237
Holding in Top 10
9
Calls
$90.6M
Puts
$63.9M
Top Buyers
| 1 | +$54.2M | |
| 2 | +$45.1M | |
| 3 | +$30.8M | |
| 4 |
Capital International Investors
Los Angeles,
California
|
+$26.3M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$21.9M |
Top Sellers
| 1 | -$78.5M | |
| 2 | -$32.1M | |
| 3 | -$30.5M | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$29.1M |
| 5 |
OFM
Omega Fund Management
Boston,
Massachusetts
|
-$14.7M |